Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27Kip1 accumulation

American Journal of Pathology

Volumn 182, Issue 5, 2013, Pages 1854-1864

  Sistrunk, Christopher ^a   Kim, Sun Hye ^a   Wang, Xian ^a   Lee, Sung Hyun ^a   Kim, Yongbaek ^b   MacIas, Everardo ^c   Rodriguez Puebla, Marcelo L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; S PHASE KINASE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; FEMALE; HAIR FOLLICLE; HYPOPLASIA; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPIDERMIS; GENE DELETION; HUMANS; KINETICS; MICE; MICE, INBRED C57BL; PAPILLOMA; S-PHASE KINASE-ASSOCIATED PROTEINS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84876525804     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.016     Document Type: Article

References (48)

1. A.M. Weissman Themes and variations on ubiquitylation Nat Rev Mol Cell Biol 2 2001 169 178
2. M.A. Gregory, and S.R. Hann c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells Mol Cell Biol 20 2000 2423 2435
3. K.I. Nakayama, and K. Nakayama Ubiquitin ligases: cell-cycle control and cancer Nat Rev Cancer 6 2006 369 381
4. F. Bahram, N. von der Lehr, C. Cetinkaya, and L.G. Larsson c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover Blood 95 2000 2104 2110
5. Z.K. Yu, J.L. Gervais, and H. Zhang Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins Proc Natl Acad Sci U S A 95 1998 11324 11329
6. T. Kamura, T. Hara, S. Kotoshiba, M. Yada, N. Ishida, H. Imaki, S. Hatakeyama, K. Nakayama, and K.I. Nakayama Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation Proc Natl Acad Sci U S A 100 2003 10231 10236
7. D. Tedesco, J. Lukas, and S.I. Reed The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2) Genes Dev 16 2002 2946 2957
8. Y. Hiramatsu, K. Kitagawa, T. Suzuki, C. Uchida, T. Hattori, H. Kikuchi, T. Oda, S. Hatakeyama, K.I. Nakayama, T. Yamamoto, H. Konno, and M. Kitagawa Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination Cancer Res 66 2006 8477 8483
9. H. Huang, K.M. Regan, F. Wang, D. Wang, D.I. Smith, J.M. van Deursen, and D.J. Tindall Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation Proc Natl Acad Sci U S A 102 2005 1649 1654
10. M.S. Song, S.J. Song, S.J. Kim, K. Nakayama, K.I. Nakayama, and D.S. Lim Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition Oncogene 27 2008 3176 3185
11. M. Kitagawa, S.H. Lee, and F. McCormick Skp2 suppresses p53-dependent apoptosis by inhibiting p300 Mol Cell 29 2008 217 231
12. C. Bai, P. Sen, K. Hofmann, L. Ma, M. Goebl, J.W. Harper, and S.J. Elledge SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box Cell 86 1996 263 274
13. A.C. Carrano, E. Eytan, A. Hershko, and M. Pagano SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat Cell Biol 1 1999 193 199
14. K. Nakayama, H. Nagahama, Y.A. Minamishima, M. Matsumoto, I. Nakamichi, K. Kitagawa, M. Shirane, R. Tsunematsu, T. Tsukiyama, N. Ishida, M. Kitagawa, K. Nakayama, and S. Hatakeyama Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overeduplication EMBO J 19 2000 2069 2081
15. K. Nakayama, H. Nagahama, Y.A. Minamishima, S. Miyake, N. Ishida, S. Hatakeyama, M. Kitagawa, S. Iemura, T. Natsume, and K.I. Nakayama Skp2-mediated degradation of p27 regulates progression into mitosis Dev Cell 6 2004 661 672
16. K.I. Nakayama, and K. Nakayama Regulation of the cell cycle by SCF-type ubiquitin ligases Semin Cell Dev Biol 16 2005 323 333
17. E. Latres, R. Chiarle, B.A. Schulman, N.P. Pavletich, A. Pellicer, G. Inghirami, and M. Pagano Role of the F-box protein Skp2 in lymphomagenesis Proc Natl Acad Sci U S A 98 2001 2515 2520
18. A.C. Carrano, and M. Pagano Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression J Cell Biol 153 2001 1381 1390
19. Y. Kudo, S. Kitajima, S. Sato, M. Miyauchi, I. Ogawa, and T. Takata High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas Cancer Res 61 2001 7044 7047
20. E.H. Shim, L. Johnson, H.L. Noh, Y.J. Kim, H. Sun, C. Zeiss, and H. Zhang Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate Cancer Res 63 2003 1583 1588
21. J. Slingerland, and M. Pagano Regulation of the cdk inhibitor p27 and its deregulation in cancer J Cell Physiol 183 2000 10 17
22. A. Osoegawa, I. Yoshino, S. Tanaka, K. Sugio, T. Kameyama, M. Yamaguchi, and Y. Maehara Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer J Clin Oncol 22 2004 4165 4173
23. Q. Li, M. Murphy, J. Ross, C. Sheehan, and J.A. Carlson Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship J Cutan Pathol 31 2004 633 642
24. C. Sistrunk, E. Macias, K. Nakayama, Y. Kim, and M.L. Rodriguez-Puebla Skp2 is necessary for myc-induced keratinocyte proliferation but dispensable for myc oncogenic activity in the oral epithelium Am J Pathol 178 2011 2470 2477
25. L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, and A. Bradley Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 1992 215 221
26. M.L. Rodriguez-Puebla, A.I. Robles, D.G. Johnson, M. LaCava, and C.J. Conti Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation Cell Growth Differ 9 1998 31 39
27. M. Naito, and J. DiGiovanni Genetic background and development of skin tumors C.J. Conti, T.J. Slaga, A.J. Klein-Szanto, Carcinogenesis A Comprehensive Survey 1989 Raven Press New York 187 212
28. J. Philipp, K. Vo, K.E. Gurley, K. Seidel, and C.J. Kemp Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis Oncogene 18 1999 4689 4698
29. A. Klein-Szanto Melanotic and non-melanotic tumours of the rodent skin. Pathology of Neoplasia and Preneoplasia in Rodents 1997 European Late Effects Project Schattauer pp 1-18
30. E. Macias, P.L. de Marval, A. Senderowicz, J. Cullen, and M.L. Rodriguez-Puebla Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis Cancer Res 68 2008 162 171
31. K. Harada, Supriatno, Y. Kawashima, Y. Itashiki, H. Yoshida, and M. Sato Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells Oral Oncol 41 2005 623 630
32. F. Jiang, N.P. Caraway, R. Li, and R.L. Katz RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells Oncogene 24 2005 3409 3418
33. R.J. Morris, S.M. Fischer, and T.J. Slaga Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen Cancer Res 46 1986 3061 3066
34. A. Ray, M.K. James, S. Larochelle, R.P. Fisher, and S.W. Blain p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes Mol Cell Biol 29 2009 986 999
35. T. Slaga Mechanism involved in two-stage carcinogenesis in mouse skin T. Slaga, Mechanism of Tumor Promotion 1984 CRC Press Boca Raton 1 16
36. R.J. Morris Keratinocyte stem cells: targets for cutaneous carcinogens J Clin Invest 106 2000 3 8
37. S.H. Lee, and F. McCormick Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells J Mol Med 83 2005 296 307
38. S.R. Grossman p300/CBP/p53 interaction and regulation of the p53 response Eur J Biochem 268 2001 2773 2778
39. M.S. Song, S.J. Song, S.Y. Kim, H.J. Oh, and D.S. Lim The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex EMBO J 27 2008 1863 1874
40. D. Matallanas, D. Romano, K. Yee, K. Meissl, L. Kucerova, D. Piazzolla, M. Baccarini, J.K. Vass, W. Kolch, and E. O'Neill RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein Mol Cell 27 2007 962 975
41. P.L. Miliani de Marval, E. Macias, C.J. Conti, and M.L. Rodriguez-Puebla Enhanced malignant tumorigenesis in Cdk4 transgenic mice Oncogene 23 2004 1863 1873
42. E. Macias, Y. Kim, P.L. Miliani de Marval, A. Klein-Szanto, and M.L. Rodriguez-Puebla Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis Cancer Res 67 2007 9713 9720
43. M. Cheng, P. Olivier, J.A. Diehl, M. Fero, M.F. Roussel, J.M. Roberts, and C.J. Sherr The p21(Cip1) and p27(Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts EMBO J 18 1999 1571 1583
44. H.K. Lin, Z. Chen, G. Wang, C. Nardella, S.W. Lee, C.H. Chan, W.L. Yang, J. Wang, A. Egia, K.I. Nakayama, C. Cordon-Cardo, J. Teruya-Feldstein, and P.P. Pandolfi Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence Nature 464 2010 374 379
45. Q. Chen, W. Xie, D.J. Kuhn, P.M. Voorhees, A. Lopez-Girona, D. Mendy, L.G. Corral, V.P. Krenitsky, W. Xu, L. Moutouh-de Parseval, D.R. Webb, F. Mercurio, K.I. Nakayama, K. Nakayama, and R.Z. Orlowski Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy Blood 111 2008 4690 4699
46. T. Sanada, S. Yokoi, S. Arii, K. Yasui, I. Imoto, and J. Inazawa Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancers Cancer Sci 95 2004 969 976
47. A.M. Oliveira, S.H. Okuno, A.G. Nascimento, and R.V. Lloyd Skp2 protein expression in soft tissue sarcomas J Clin Oncol 21 2003 722 727
48. C. Langner, R. von Wasielewski, M. Ratschek, P. Rehak, and R. Zigeuner Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma Urology 64 2004 611 616